site stats

Cytokinetics ticker

WebCytokinetics, Incorporated CYTK: Raising target price to $38.00 CYTOKINETICS INC has an Investment Rating of HOLD; a target price of $38.000000; an Industry Subrating of … Find the latest Cytokinetics, Incorporated (CYTK) stock discussion in Yahoo … See the company profile for Cytokinetics, Incorporated (CYTK) including business … View the basic CYTK option chain and compare options of Cytokinetics, … SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- … Discover historical prices for CYTK stock on Yahoo Finance. View daily, weekly or … At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio … Find out all the key statistics for Cytokinetics, Incorporated (CYTK), … Get the detailed quarterly/annual income statement for Cytokinetics, Incorporated … Find out the direct holders, institutional holders and mutual fund holders for … See Cytokinetics, Incorporated (CYTK) Environment, Social and Governance … WebCytokinetics, Inc. (CYTK) Stock Price & News - Google Finance Markets +0.85 Home CYTK • NASDAQ Cytokinetics, Inc. Follow Share $35.84 Apr 3, 9:39:48 AM GMT-4 · …

Cytokinetics - AnnualReports.com

WebCytokinetics is a biopharmaceutical company with a focus on the discovery, development, and commercialization of muscle activators and muscle inhibitors as potential treatments … WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating … christian homeschooling in texas https://fjbielefeld.com

CYTK Cytokinetics Inc. Stock Price & News - WSJ

WebApr 6, 2024 · Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as … WebFeb 17, 2024 · It is currently -18.08% from its 52-week high and 51.01% from its 52-week low. How much is Cytokinetics stock worth today? ( NASDAQ: CYTK) Cytokinetics currently has 94,631,001 outstanding shares. With Cytokinetics stock trading at $45.71 per share, the total value of Cytokinetics stock (market capitalization) is $4.33B. WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 … george wettling bugle call rag

CYTK Stock Forecast, Price & News (Cytokinetics)

Category:CYTK Cytokinetics Inc. Annual Income Statement MarketWatch

Tags:Cytokinetics ticker

Cytokinetics ticker

Cytokinetics: Contact Details and Business Profile - RocketReach

WebBonnie Charpentier SVP Regulatory & Compliance at Cytokinetics, is currently unranked, see this insider's latest transactions. Top Stocks. Top Analyst Stocks Top Smart Score Stocks ... SVP Regulatory & Compliance at Cytokinetics, holds 0.00 shares in Cytokinetics (Ticker: CYTK). See the Hottest Stocks Based on Insider Trading > Bonnie ... WebMar 4, 2024 · Today is shaping up negative for Cytokinetics, ... (ticker: BBBY) stock was down nearly 20% at 83 cents. In a reverse stock split, each outstanding share is converted into a fraction of the share.

Cytokinetics ticker

Did you know?

WebHistorical PS ratio values for Cytokinetics (CYTK) over the last 10 years. The current P/S ratio for Cytokinetics as of April 07, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide. Compare CYTK With Other Stocks From: To: Zoom: 0 10 20 30 40 Stock Price 0 2 4 6 8 TTM Sales per Share WebMar 31, 2024 · Cytokinetics Muscle Biology Therapies Home empowering muscle empowering lives Cytokinetics is committed to our mission of developing potential medicines that may improve the …

WebDec 30, 2024 · Mizuho Securities analyst Salim Syed maintained a Buy rating on Cytokinetics (CYTK - Research Report) today and set a price target of $80.00. The …

Web2 days ago · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential … WebCytokinetics Inc. Annual stock financials by MarketWatch. View the latest CYTK financial statements, income statements and financial ratios.

Web2 days ago · Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as …

WebDec 13, 2024 · PDUFA Target Action Date is February 28, 2024 Cytokinetics to Host Conference Call and Webcast on December 14, 2024 at 8:30 am Eastern Time SOUTH SAN FRANCISCO, Calif., Dec. 13, 2024 (GLOBE ... christian home schoolingWebCytokinetics Incorporated 280 East Grand Avenue South San Francisco, CA 94080 United States. Website. Investor relation . Ratios; Stock Price Chart; Annual Returns; Financial … christian homeschool memesWebwww.cytonics.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology … george w gleason nh obituaryWebCytokinetics (CYTK) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. ... Stock Ticker Symbol Market Type; Cytokinetics Inc: CYTK: NASDAQ: Common Stock Price Change Change Percent Stock Price Last Traded -1.73-4.67%: 35.33: 20:00:00: Open Price Low Price High Price george w fultonWebFeb 28, 2024 · The US FDA has issued a Complete Response Letter to Cytokinetics ( NASDAQ: CYTK) for omecamtiv mecarbil for heart failure with reduced ejection fraction. Shares are down ~8% in post-market trading ... george w gilbert md ocala flWebCytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential … george w. footeWebApr 13, 2024 · Issuer Name and Ticker or Trading Symbol CYTOKINETICS INC [ CYTK] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director: 10% Owner: X: Officer (give title below) Other (specify below) EVP Research & Development: 3. Date of Earliest Transaction (Month/Day/Year) george w fitzpatrick \u0026 son carlisle pa